Published in Cancer Weekly, February 12th, 2008
"This report describes the development of the algorithm and results of the blinded test for stage 1. We derived the decision algorithm used in this study from the analysis of serum samples from patients with prostate cancer (n=181) and benign prostatic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.